Lifeward (LFWD) Proxy filing summary

Executive summary

• The annual and extraordinary general meeting is scheduled for October 30, 2026, with in-person attendance planned and remote options if needed.

• The Board recommends voting in favor of all proposals, including director elections, compensation matters, and auditor re-appointment.

• Shareholders of record as of September 30, 2026, are eligible to vote, with detailed proxy and voting instructions provided.

Voting matters and shareholder proposals

• Proposals include re-election of Class III directors, election of an external director, approval of director and CEO compensation, issuance of shares above Nasdaq exchange cap, renewal of compensation policy, auditor re-appointment, say-on-pay, and advisory vote on say-on-pay frequency.

• Board recommends voting "FOR" Proposals 1-8 and "EVERY YEAR" for Proposal 9.

• Special Majority is required for certain proposals under Israeli law, particularly those involving compensation and external director election.

• Shareholder proposals for the 2027 AGM must be submitted by May 28, 2027, with additional requirements for director nominations.

Board of directors and corporate governance

• Board currently has eight seats, six occupied; after the meeting, seven directors are expected to serve.

• Board is divided into three classes, with Class III directors up for re-election until 2029.

• Board leadership structure separates CEO and Chairman roles, with active risk oversight and committee structure for audit, compensation, and governance.

• Director independence is assessed under Nasdaq and Israeli law; currently, four directors are independent.

• Nominating committee considers diversity of experience and skills but has no formal diversity policy.